Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Prothena Corp. plc
Description mAb targeting melanoma cell adhesion molecule (MCAM; MUC18; CD146)
Molecular Target Melanoma cell adhesion molecule (MCAM) (MUC18) (CD146)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today